Pet Drug Reports

Codeine: adverse event reports in all combinations

Active ingredient, alone and in combinations

The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand.

Read this first. FDA says this about the data:

An API dataset query result cannot be used to estimate the risk associated with the product or compare one drug or device product with another. When looking at the results, be aware that there is no certainty that the reported drug or device caused the adverse event. This dataset should not be the sole source of information for clinical decision-making or other assumptions about the safety or effectiveness of a product. The adverse event may have been related to an underlying disease, other drugs used at the same time or other non-drug related sources.

FDA Center for Veterinary Medicine publishes these words. Source: Adverse Event Reports for Animal Drugs and Devices, read on . The data have the reports that FDA received through .

This page is not veterinary advice. For an animal that is ill, speak to a veterinarian.

Contacting a veterinarianHow to report to FDA

FDA reports received through . Counts include this ingredient alone and in combinations. Why brand names have no separate count.

From July 2012 to June 2026, FDA received 98 adverse event reports that name a drug with codeine, alone or in a combination. 2 sets of active ingredients with codeine have a drug page.

Of the 98 reports, 96 (98%) are about dogs. 2 reports are about people who were exposed to the drug (2%). In January to March 2026, FDA received 3 reports that name codeine, alone or in a combination. The signs that appear in the largest number of the 98 reports are "Death by euthanasia", "Lethargy" and "Vomiting". A report is not proof that a drug caused a sign.

Reports that name this ingredient fell by 18.2% in the 12 months to June 2026, compared with the 12 months before. Reports for all animal drugs fell by 4.6% in the same periods. The newest months can get more reports in a later update. Reports about dogs are 98% of the reports that name this ingredient, and 72.6% of all reports.

Search engines list an ingredient page with 500 reports or more in all years. The page also needs 30 reports or more in the 12 months to June 2026. This page is under one of these numbers. The site keeps the page and keeps it out of search engines.

Reports in the latest closed quarter

Reports that name codeine, by the quarter in which FDA received them
SpeciesJan to Mar 2026Oct to Dec 2025Jan to Mar 2025
All species3010
Dog3010
Cat000
Horse000
Other or not given000

January to March 2026 is the latest closed quarter in the data.

All updatesFeed of updates (RSS)

Drug pages with codeine

A report names a drug by its set of active ingredients. Each set with codeine that has a drug page is in the table, in order of name. The table has 2 sets.

Drug pages with codeine, in order of name, with the reports of each page
Active ingredientsReports, all yearsReports, latest 12 months
Acetaminophen + Codeine204
Codeine7915

A report can name more than one set, so the counts of the sets can add to more than the count of the page.

An API dataset query result cannot be used to estimate the risk associated with the product or compare one drug or device product with another.

FDA Center for Veterinary Medicine. Source: Adverse Event Reports for Animal Drugs and Devices

Signs that the reports list

A sign is a coded term from the report. The words in brackets are a plain gloss of the term. The percentage is the share of the 98 reports that list the sign. One report can list more than one sign and more than one drug.

The sign that is in the largest number of the reports comes first.

  1. Death by euthanasia[the animal was euthanized]19.4%19 reports
  2. Lethargy[unusually tired or inactive]18.4%18 reports
  3. Vomiting18.4%18 reports
  4. Diarrhoea[diarrhea]15.3%15 reports
  5. Decreased appetite14.3%14 reports
  6. Elevated alanine aminotransferase (ALT)[a liver enzyme above the normal range]13.3%13 reports
  7. Pain NOS[NOS: not otherwise specified]13.3%13 reports
  8. Elevated total bilirubin[bilirubin above the normal range]11.2%11 reports
  9. Elevated aspartate aminotransferase (AST)[a liver and muscle enzyme above the normal range]10.2%10 reports
  10. Lack of efficacy - NOS[the product did not have the expected effect]10.2%10 reports
  11. Not eating10.2%10 reports
  12. Death9.2%9 reports
  13. Elevated serum alkaline phosphatase (ALP)[a liver and bone enzyme above the normal range]9.2%9 reports
Show the next 16 signs
  1. Other abnormal test result NOS[abnormal laboratory result, type not specified]9.2%9 reports
  2. Panting9.2%9 reports
  3. Vocalisation[crying out or unusual noise]9.2%9 reports
  4. Anorexia[not eating]8.2%8 reports
  5. Fever8.2%8 reports
  6. Inappetence[reduced appetite]8.2%8 reports
  7. Emesis (multiple)[vomiting more than once]7.1%7 reports
  8. Hypoalbuminaemia[low blood albumin]7.1%7 reports
  9. Injection site swelling[swelling where the injection was given]7.1%7 reports
  10. Lymphopenia[low lymphocyte count]7.1%7 reports
  11. Monocytosis[high monocyte count]7.1%7 reports
  12. Restlessness7.1%7 reports
  13. Drooling6.1%6 reports
  14. Elevated creatinine[a kidney value above the normal range]6.1%6 reports
  15. Hypokalaemia[low blood potassium]6.1%6 reports
  16. Leucocytosis NOS[high white blood cell count]6.1%6 reports

Download all signs (CSV)

Reports by species

  • Dog98%96
  • Human exposure2%2

Reports for each month, Jul 2021 to Jun 2026

Dog66 reports. Largest count in one month: 5 (Jul 2025)
Cat0 reports

No chart: no month has 5 or more reports.

Horse0 reports

No chart: no month has 5 or more reports.

Other or not given1 report

No chart: no month has 5 or more reports.

The month is the month in which FDA received the report. Each chart has its own scale. FDA says that a report can take 3 to 6 months to reach the public data. The newest months can get more reports in a later update.

Reports by year

  • Dog
  • Cat
  • Horse
  • Other or not given
Reports that name codeine, by the year in which FDA received them and by species
YearDogCatHorseOther or not givenAll species
202680008
20252300023
20242200022
202380008
202240015
202140004
201990009
201800011
201750005
201660006
201530003
201430003
201210001

2026 has the reports that FDA received through Jun 2026. Download the years (CSV)

What the reports record

Outcome at the time of the report

  • Recovered/Normal15.3%15
  • Recovered with Sequela[recovered, with a lasting effect]1%1
  • Ongoing33.7%33
  • Died9.2%9
  • Euthanized19.4%19
  • Outcome Unknown21.4%21

An outcome in a report is not proof that the drug caused it. The person who sends the report gives the outcome. Each share is of the 98 reports that name codeine.

Kind of report

  • Safety issue85.7%84
  • Lack of expected effectiveness4.1%4
  • Both safety and lack of expected effectiveness9.2%9
  • Manufacturing or product defect1%1
  • Other0%0

Age of the animal

  • Under 1 year2%2
  • 1 to 3 years11.2%11
  • 4 to 7 years24.5%24
  • 8 to 11 years38.8%38
  • 12 years and over21.4%21
  • Age not given2%2

Each share of kind and age is of the 98 reports that name codeine.

Approved animal drugs with this active ingredient (FDA Green Book)

This section is reference data. It has no report count.

The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand.

The Green Book lists no approved animal drug with this active ingredient. FDA also receives reports for human drugs and compounded drugs that veterinarians prescribe.

FDA pages for this ingredient

The site checked these addresses on . The links open in a new tab.

Cite this page

Pet Drug Reports. Codeine, all combinations: adverse event reports that FDA received. https://petdrugreports.com/ingredient/codeine/ Source: FDA Center for Veterinary Medicine, openFDA Animal and Veterinary adverse event reports, export of . Reports received through .

Where the data come from

The counts come from the openFDA Animal and Veterinary adverse event files, export of 30 Oct 2026. The files have the reports that the FDA Center for Veterinary Medicine received through 26 Jun 2026. The files mask brand and manufacturer names. The site counts a drug by the active ingredients that each record gives, and gives no count to a brand, an application or a company. Ingredient names and the lists of approved products follow the FDA Green Book of 2 Nov 2026. Ingredient names follow the Green Book, with salts and forms as FDA lists them.

The site does not publish report text, lot numbers or details of a reporter. FDA's record is the authority. See how the site counts reports, the data sources and the corrections page.

Questions about these reports

Which brand are these reports about?

The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand. The Green Book lists no approved animal drug with this active ingredient.

Do the reports show that the ingredient caused the signs?

No. A report can name more than one drug, and a drug can have more than one active ingredient. FDA states this about the data.

When looking at the results, be aware that there is no certainty that the reported drug or device caused the adverse event.

The adverse event may have been related to an underlying disease, other drugs used at the same time or other non-drug related sources.

FDA Center for Veterinary Medicine. Source: Adverse Event Reports for Animal Drugs and Devices

How many reports did FDA receive in the latest 12 months?

FDA received 18 reports in the 12 months to June 2026. It received 22 reports in the 12 months before. FDA says that a report can take 3 to 6 months to reach the public data. The newest months can get more reports in a later update.

What kinds of report are in the count?

Of the 98 reports received from July 2012 to June 2026, 85.7% are about a safety issue only. 13.3% are about a lack of expected effectiveness, alone or with a safety issue. 1% are about a defect of the product or its package.